Literature DB >> 31583191

"Pseudo-syndromes" associated with Parkinson disease, dementia, apathy, anxiety, and depression.

Howard D Weiss1, Gregory M Pontone1.   

Abstract

PURPOSE OF REVIEW: Physicians treating patients with Parkinson disease must evaluate not only motor symptoms but also acquire expertise in assessing the complex behavioral features that often accompany the disease, such as dementia, apathy, anxiety, and depression. RECENT
FINDINGS: There is a risk of diagnostic confusion and error because many of the behavioral and motor symptoms accentuate, overlap, or mimic each other.
SUMMARY: Awareness of potential diagnostic pitfalls and "pseudo-syndromes" should lead to more accurate clinical assessment and better care for our patients.
© 2019 American Academy of Neurology.

Entities:  

Year:  2019        PMID: 31583191      PMCID: PMC6745743          DOI: 10.1212/CPJ.0000000000000644

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  38 in total

1.  Atypical antipsychotics and parkinsonism.

Authors:  Paula A Rochon; Therese A Stukel; Kathy Sykora; Sudeep Gill; Susan Garfinkel; Geoffrey M Anderson; Sharon-Lise T Normand; Muhammad Mamdani; Philip E Lee; Ping Li; Susan E Bronskill; Connie Marras; Jerry H Gurwitz
Journal:  Arch Intern Med       Date:  2005-09-12

2.  Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients.

Authors:  Lucile Brun; Romain Lefaucheur; Damien Fetter; Stéphane Derrey; Alaina Borden; David Wallon; Bertrand Bourre; David Maltête
Journal:  Clin Neurol Neurosurg       Date:  2014-10-16       Impact factor: 1.876

Review 3.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

Review 4.  Apathy in Parkinson's disease: A systematic review and meta-analysis.

Authors:  Melina G H E den Brok; Jan Willem van Dalen; Willem A van Gool; Eric P Moll van Charante; Rob M A de Bie; Edo Richard
Journal:  Mov Disord       Date:  2015-03-18       Impact factor: 10.338

Review 5.  Depression rating scales in Parkinson's disease: A critical review updating recent literature.

Authors:  Elizabeth Torbey; Nancy A Pachana; Nadeeka N W Dissanayaka
Journal:  J Affect Disord       Date:  2015-06-10       Impact factor: 4.839

6.  Behavioral effects of levodopa.

Authors:  Isabelle Beaulieu-Boire; Anthony E Lang
Journal:  Mov Disord       Date:  2014-12-09       Impact factor: 10.338

7.  Subjective Cognitive Complaints in Parkinson Disease Without Dementia: A Preliminary Study.

Authors:  Daniel P Koster; Christopher I Higginson; Elizabeth E MacDougall; Vicki L Wheelock; Karen A Sigvardt
Journal:  Appl Neuropsychol Adult       Date:  2014-12-12       Impact factor: 2.248

8.  Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study.

Authors:  Charles H Adler; Thomas G Beach; Joseph G Hentz; Holly A Shill; John N Caviness; Erika Driver-Dunckley; Marwan N Sabbagh; Lucia I Sue; Sandra A Jacobson; Christine M Belden; Brittany N Dugger
Journal:  Neurology       Date:  2014-06-27       Impact factor: 9.910

Review 9.  Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease.

Authors:  Angie A Kehagia; Roger A Barker; Trevor W Robbins
Journal:  Lancet Neurol       Date:  2010-09-27       Impact factor: 44.182

10.  Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study.

Authors:  Nahathai Wongpakaran; Robert van Reekum; Tinakon Wongpakaran; Diana Clarke
Journal:  Ann Gen Psychiatry       Date:  2007-02-21       Impact factor: 3.455

View more
  5 in total

Review 1.  The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.

Authors:  Sandra Abou Kassm; Wadih Naja; Ramzi Haddad; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2021-03-03       Impact factor: 5.285

2.  Non-Motor Symptoms of Parkinson's Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction.

Authors:  Ayan Hussein; Christopher A Guevara; Pamela Del Valle; Swati Gupta; Deanna L Benson; George W Huntley
Journal:  Neuroscientist       Date:  2021-05-08       Impact factor: 7.235

3.  Computational Modeling for Neuropsychological Assessment of Bradyphrenia in Parkinson's Disease.

Authors:  Alexander Steinke; Florian Lange; Caroline Seer; Merle K Hendel; Bruno Kopp
Journal:  J Clin Med       Date:  2020-04-18       Impact factor: 4.241

Review 4.  Apathy in Parkinson's Disease: Defining the Park Apathy Subtype.

Authors:  Ségolène De Waele; Patrick Cras; David Crosiers
Journal:  Brain Sci       Date:  2022-07-14

5.  ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson's Disease.

Authors:  Shanti Diwakarla; Rachel M McQuade; Remy Constable; Olivia Artaiz; Enie Lei; Kevin J Barnham; Paul A Adlard; Robert A Cherny; Madeleine R Di Natale; Hongyi Wu; Xin-Yi Chai; Victoria A Lawson; David I Finkelstein; John B Furness
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.